Crossmark

Engineered enzymes for the synthesis of pharmaceuticals and other high-value products

Crossref DOI link: https://doi.org/10.1038/s44160-023-00417-0

Published Online: 2024-01-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Reetz, Manfred T. https://orcid.org/0000-0001-6246-647X
Qu, Ge https://orcid.org/0000-0002-0711-169X
Sun, Zhoutong https://orcid.org/0000-0002-9923-0951
License Information

Text and Data Mining valid from 2024-01-04

Version of Record valid from 2024-01-04
More Information

Article History

Received: 30 March 2023

Accepted: 13 September 2023

First Online: 4 January 2024

Competing interests

: The authors declare no competing interests.